Tilray Brands, Inc.
United States·USD
Congressional Trades
Whale Activity
- Increased2
- New2
- Held1
- Decreased3
- Closed0
- No prior filing0
| Filer | Shares | Value | Change |
|---|---|---|---|
| CITADEL ADVISORS LLC | 868.1K | $3.9M | increased |
| Point72 Asset Management, L.P. | 648.5K | $2.9M | new |
| BlackRock, Inc. | 461.7K | $2.1M | increased |
| D. E. Shaw & Co., Inc. | 2.0M | $2.0M | held |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 348.7K | $1.6M | decreased |
| D. E. Shaw & Co., Inc. | 148.4K | $666K | decreased |
| TWO SIGMA INVESTMENTS, LP | 135.9K | $610K | decreased |
| MILLENNIUM MANAGEMENT LLC | 31.2K | $140K | new |
KeyVex tracks a curated set of large 13F filers plus the largest positions in recent filings, so this is a sample of institutional activity, not the whole market.
Insider Trading
Recent Insider Transactions
| Insider | Type | Shares | Price | Value | Date | |
|---|---|---|---|---|---|---|
| Gendel MitchellGlobal General Counsel | Purchase | +2,500 | $4.43 | $11K | Aug 6, 2026 | Form 4 ↗ |
| Merton Carl AChief Financial Officer | Purchase | +10.0K | $4.62 | $46K | Aug 4, 2026 | Form 4 ↗ |
| FALTISCHEK DENISE MChief Strategy Officer | Purchase | +2,500 | $4.78 | $12K | Aug 3, 2026 | Form 4 ↗ |
| Hopkinson David G.Director | Sale | −33.6K | $6.94 | $233K | Apr 21, 2026 | Form 4 ↗ |
| Cohen Steven MichaelDirector | Option exercise | +12.4K | $8.99 | $112K | Jan 7, 2026 | Form 4 ↗ |
| SIMON IRWIN DPresident and CEO | Tax withholding | −374.3K | $0.58 | $217K | Jul 31, 2025 | Form 4 ↗ |
| SIMON IRWIN DPresident and CEO | Option exercise | +706.2K | $0.58 | $410K | Jul 31, 2025 | Form 4 ↗ |
| Merton Carl AChief Financial Officer | Tax withholding | −49.8K | $0.58 | $29K | Jul 31, 2025 | Form 4 ↗ |
| Merton Carl AChief Financial Officer | Option exercise | +93.9K | $0.58 | $54K | Jul 31, 2025 | Form 4 ↗ |
| Gendel MitchellGlobal General Counsel | Purchase | +6,000 | $0.58 | $3K | Jul 31, 2025 | Form 4 ↗ |
| Gendel MitchellGlobal General Counsel | Tax withholding | −49.8K | $0.58 | $29K | Jul 31, 2025 | Form 4 ↗ |
| Gendel MitchellGlobal General Counsel | Option exercise | +93.9K | $0.58 | $54K | Jul 31, 2025 | Form 4 ↗ |
| FALTISCHEK DENISE MChief Strategy Officer | Tax withholding | −49.8K | $0.58 | $29K | Jul 31, 2025 | Form 4 ↗ |
| FALTISCHEK DENISE MChief Strategy Officer | Option exercise | +93.9K | $0.58 | $54K | Jul 31, 2025 | Form 4 ↗ |
| FALTISCHEK DENISE MChief Strategy Officer | Tax withholding | −138.4K | $0.61 | $84K | Jul 30, 2025 | Form 4 ↗ |
| FALTISCHEK DENISE MChief Strategy Officer | Option exercise | +261.2K | $0.61 | $159K | Jul 30, 2025 | Form 4 ↗ |
| Herhalt Johann MichaelDirector | Tax withholding | −65.9K | $0.61 | $40K | Jul 30, 2025 | Form 4 ↗ |
| Herhalt Johann MichaelDirector | Option exercise | +124.4K | $0.61 | $76K | Jul 30, 2025 | Form 4 ↗ |
| Looney Thomas P.Director | Option exercise | +124.4K | $0.61 | $76K | Jul 30, 2025 | Form 4 ↗ |
| Hopkinson David G.Director | Option exercise | +124.4K | $0.61 | $76K | Jul 30, 2025 | Form 4 ↗ |
Fund Holders
| Fund | Shares | Value | % of fund | As of |
|---|---|---|---|---|
| Amplify Alternative Harvest ETF Amplify ETF Trust | 2.5M | $11.1M | 10.03% | Jun 30, 2026 |
| VANGUARD HEALTH CARE INDEX FUND VANGUARD WORLD FUND | 347.4K | $1.9M | 0.01% | May 31, 2026 |
| iShares U.S. Small-Cap Equity Factor ETF iShares Trust | 86.8K | $394K | 0.01% | Jul 31, 2026 |
| Fidelity Nasdaq Composite Index Fund Fidelity Concord Street Trust | 69.5K | $383K | 0.00% | May 31, 2026 |
| Dimensional International Small Cap ETF Dimensional ETF Trust | 79.1K | $357K | 0.01% | Jul 31, 2026 |
| AdvisorShares Pure Cannabis ETF AdvisorShares Trust | 76.3K | $342K | 1.00% | Jun 30, 2026 |
| Dimensional International Core Equity Market ETF Dimensional ETF Trust | 68.9K | $311K | 0.00% | Jul 31, 2026 |
| State Street(R) SPDR(R) S&P(R) International Small Cap ETF SPDR INDEX SHARES FUNDS | 59.9K | $269K | 0.03% | Jun 30, 2026 |
| Fidelity MSCI Health Care Index ETF FIDELITY COVINGTON TRUST | 57.3K | $260K | 0.01% | Jul 31, 2026 |
| State Street(R) SPDR(R) Portfolio Developed World ex-US ETF SPDR INDEX SHARES FUNDS | 46.7K | $210K | 0.00% | Jun 30, 2026 |
Mutual funds and ETFs whose N-PORT filings list TLRY's shares (CUSIP 88688T209), each fund at its latest report since Mar 7, 2026, largest positions first. Bonds, options and short positions are left out.
Activist & Passive Stakes
No 13D/13G beneficial-ownership filings on record.
Corporate Lobbying
Government Contracts
No federal contract awards found for Tilray Brands, Inc..
U.S. Patents
No USPTO patent applications found for Tilray Brands, Inc..
Annual Financials
No annual XBRL figures on record for TLRY. KeyVex's fundamentals cover about 130 large companies so far.
Stock Splits
- 1-for-10Reverse splitDec 2, 2025
Split dates and ratios from the price history · Close Prices from Tiingo.com
Material Events (8-K)
- 8-K · Items 3.02Unregistered sale of equitySep 14, 2026
EDGAR ↗ - 8-K · Items 3.02Unregistered sale of equityAug 10, 2026
EDGAR ↗ - 8-K · Items 2.02, 9.01Results of operationsJul 28, 2026
EDGAR ↗ - 8-K · Items 3.02Unregistered sale of equityJun 30, 2026
EDGAR ↗ - 8-K · Items 3.02Unregistered sale of equityJun 9, 2026
EDGAR ↗
About Tilray Brands, Inc.
. Our Company Tilray Brands, Inc., a Delaware corporation (collectively, along with its subsidiaries, the “Company”, “Tilray”, “we”, “us” and “our”) is a leading global lifestyle consumer products company, which was incorporated on January 24, 2018 and is headquartered in Leamington and New York, with operations in Canada, the United States, Europe, Australia, and Latin America that is leading as a transformative force at the nexus of cannabis, beverage, wellness, and entertainment, elevating lives through moments of connection. Tilray’s mission is to be a leading premium lifestyle company with a house of brands and innovative products that inspire joy and wellness, while creating memorable…